Epstein–Barr Virus (EBV)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

How does Epstein–Barr virus (EBV) contribute to the development of gastric cancer?

Epstein-Barr Virus (EBV), a common herpesvirus, is known for establishing a latent infection in both B cells and epithelial cells. It contributes to the development of gastric cancer by modulating the immune system, inducing epigenetic changes, and producing viral microRNAs (miRNAs).
Arrè et al. 2025 Gut Microbes 17(1): 2519703

References (Sources)

A Cancer Vaccine Induces Expansion of NY-ESO Treg Cells in Pts with Advanced Melanoma
Ebert et al. 2012
A Severe Case of lpilimumab-lnduced Guillain-Barré Syndrome Revealed by an Occlusive Enteric Neuropathy: A Differential Diagnosis for lpilimumab-lnduced Colitis
Gaudy-Marqueste et al. 2013
Current status of immunotherapy for the treatment of lung cancer
Murala et al. 2010
Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies
Brossart et al. 1999
Identiﬁcation of TRP-2 as a Human Tumor Antigen Recognized by CTL
Wang et al. 1996/1
Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developrnents
Haneklaus et al. 2013
Processing of Some Antigens by the Standard Proteasome but Not by the Immunoproteasome Results in Poor Presentation by Dendritic Cells
Morel et al. 2000

AI Chat

10/17/2026

Chat with our artificial intelligence:

Start chat!